Literature DB >> 18568073

Hedgehog signaling is critical for maintenance of the adult coronary vasculature in mice.

Kory J Lavine1, Attila Kovacs, David M Ornitz.   

Abstract

Hedgehog (HH) signaling has emerged as a critical pathway involved in the pathogenesis of a variety of tumors. As a result, HH antagonists are currently being evaluated as potential anticancer therapeutics. Conversely, activation of HH signaling in the adult heart may be beneficial, as HH agonists have been shown to increase coronary vessel density and improve coronary function after myocardial infarction. To investigate a potential homeostatic role for HH signaling in the adult heart, we ablated endogenous HH signaling in murine myocardial and perivascular smooth muscle cells. HH signaling was required for proangiogenic gene expression and maintenance of the adult coronary vasculature in mice. In the absence of HH signaling, loss of coronary blood vessels led to tissue hypoxia, cardiomyocyte cell death, heart failure, and subsequent lethality. We further showed that HH signaling specifically controlled the survival of small coronary arteries and capillaries. Together, these data demonstrate that HH signaling is essential for cardiac function at the level of the coronary vasculature and caution against the use of HH antagonists in patients with prior or ongoing heart disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568073      PMCID: PMC2430494          DOI: 10.1172/JCI34561

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.

Authors:  Juliet A Williams; Oivin M Guicherit; Beatrice I Zaharian; Yin Xu; Ling Chai; Hynek Wichterle; Charlene Kon; Christine Gatchalian; Jeffery A Porter; Lee L Rubin; Frank Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 2.  Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention and medical therapy for multivessel disease with and without left ventricular dysfunction.

Authors:  Amitra E B Caines; Malek G Massad; Jacques Kpodonu; Abdallah G Rebeiz; Alexander Evans; Alexander S Geha
Journal:  Cardiology       Date:  2004       Impact factor: 1.869

3.  Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia.

Authors:  Douglas W Losordo; Peter R Vale; Robert C Hendel; Charles E Milliken; F David Fortuin; Nancie Cummings; Richard A Schatz; Takayuki Asahara; Jeffrey M Isner; Richard E Kuntz
Journal:  Circulation       Date:  2002-04-30       Impact factor: 29.690

4.  Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Authors:  Richard P Visconti; Charlene D Richardson; Thomas N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

5.  Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.

Authors:  Michael Simons; Brian H Annex; Roger J Laham; Neal Kleiman; Timothy Henry; Harold Dauerman; James E Udelson; Ernesto V Gervino; Marilyn Pike; M J Whitehouse; Thomas Moon; Nicolas A Chronos
Journal:  Circulation       Date:  2002-02-19       Impact factor: 29.690

Review 6.  The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development.

Authors:  Nicole L Ward; Daniel J Dumont
Journal:  Semin Cell Dev Biol       Date:  2002-02       Impact factor: 7.727

7.  Medulloblastoma growth inhibition by hedgehog pathway blockade.

Authors:  David M Berman; Sunil S Karhadkar; Andrew R Hallahan; Joel I Pritchard; Charles G Eberhart; D Neil Watkins; James K Chen; Michael K Cooper; Jussi Taipale; James M Olson; Philip A Beachy
Journal:  Science       Date:  2002-08-30       Impact factor: 47.728

Review 8.  Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma.

Authors:  Juliet A Williams
Journal:  Drug News Perspect       Date:  2003-12

9.  Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation.

Authors:  F Long; X M Zhang; S Karp; Y Yang; A P McMahon
Journal:  Development       Date:  2001-12       Impact factor: 6.868

10.  Notch signaling is required for arterial-venous differentiation during embryonic vascular development.

Authors:  N D Lawson; N Scheer; V N Pham; C H Kim; A B Chitnis; J A Campos-Ortega; B M Weinstein
Journal:  Development       Date:  2001-10       Impact factor: 6.868

View more
  59 in total

Review 1.  Angiogenic therapy for cardiac repair based on protein delivery systems.

Authors:  F R Formiga; E Tamayo; T Simón-Yarza; B Pelacho; F Prósper; M J Blanco-Prieto
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 2.  Epicardial-myocardial signaling directing coronary vasculogenesis.

Authors:  Harold E Olivey; Eric C Svensson
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

3.  A method for labeling vasculature in embryonic mice.

Authors:  Jerrod L Bryson; Mark C Coles; Nancy R Manley
Journal:  J Vis Exp       Date:  2011-10-07       Impact factor: 1.355

Review 4.  Programming and reprogramming a human heart cell.

Authors:  Makoto Sahara; Federica Santoro; Kenneth R Chien
Journal:  EMBO J       Date:  2015-02-20       Impact factor: 11.598

Review 5.  Shared circuitry: developmental signaling cascades regulate both embryonic and adult coronary vasculature.

Authors:  Kory J Lavine; David M Ornitz
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

6.  Gi proteins mediate activation of the canonical hedgehog pathway in the myocardium.

Authors:  Christian J Carbe; Lan Cheng; Sankar Addya; Jessica I Gold; Erhe Gao; Walter J Koch; Natalia A Riobo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-09       Impact factor: 4.733

7.  Gli3 regulation of myogenesis is necessary for ischemia-induced angiogenesis.

Authors:  Marie-Ange Renault; Soizic Vandierdonck; Candice Chapouly; Yang Yu; Gangjian Qin; Alexandre Metras; Thierry Couffinhal; Douglas W Losordo; Qinyu Yao; Annabel Reynaud; Béatrice Jaspard-Vinassa; Isabelle Belloc; Claude Desgranges; Alain-Pierre Gadeau
Journal:  Circ Res       Date:  2013-09-17       Impact factor: 17.367

Review 8.  Is scleroderma a vasculopathy?

Authors:  Jo Nadine Fleming; Richard A Nash; William M Mahoney; Stephen Mark Schwartz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

9.  Reduced expression of Cx43 attenuates ventricular remodeling after myocardial infarction via impaired TGF-beta signaling.

Authors:  Yan Zhang; Hongtao Wang; Attila Kovacs; Evelyn M Kanter; Kathryn A Yamada
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

Review 10.  Cardiomyocyte-specific inactivation of thyroid hormone in pathologic ventricular hypertrophy: an adaptative response or part of the problem?

Authors:  Christine J Pol; Alice Muller; Warner S Simonides
Journal:  Heart Fail Rev       Date:  2010-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.